Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
CRAWFORD, PETER
1996.
The Geography of the U.S. Biotechnology Industry and Implications for the Tri‐State Region.
Annals of the New York Academy of Sciences,
Vol. 787,
Issue. 1,
p.
101.
Bye, Pascal
1997.
Productive Inertia and Technical Change.
Science, Technology and Society,
Vol. 2,
Issue. 1,
p.
131.
Athreye, Suma S.
1997.
On Markets in Knowledge.
Journal of Management & Governance,
Vol. 1,
Issue. 2,
p.
231.
Walcott, S M
1998.
The Indianapolis ‘Fortune 500’: Lilly and Regional Renaissance.
Environment and Planning A: Economy and Space,
Vol. 30,
Issue. 10,
p.
1723.
Galambos, Louis
and
Sturchio, Jeffrey L.
1998.
Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation.
Business History Review,
Vol. 72,
Issue. 2,
p.
250.
Cook-Deegan, Robert Mullan
1999.
The Commercialization of Genetic Research.
p.
13.
Korenko, George G.
1999.
Intellectual Property Protection and Industrial Growth.
The Journal of World Intellectual Property,
Vol. 2,
Issue. 1,
p.
47.
Rothaermel, Frank T.
2000.
Technological Discontinuities and the Nature of Competition.
Technology Analysis & Strategic Management,
Vol. 12,
Issue. 2,
p.
149.
Cook‐deegan, Robert Mullan
2000.
Encyclopedia of Ethical, Legal and Policy Issues in Biotechnology.
Anand, Bharat N.
and
Galetovic, Alexander
2000.
Weak Property Rights and Holdup in R&D.
Journal of Economics & Management Strategy,
Vol. 9,
Issue. 4,
p.
615.
Laestadius, Staffan
2000.
Biotechnology and the Potential for a Radical Shift of Technology in Forest Industry.
Technology Analysis & Strategic Management,
Vol. 12,
Issue. 2,
p.
193.
Mowery, David
and
Rosenberg, Nathan
2000.
The Cambridge Economic History of the United States.
p.
803.
Groenewegen, P.
2001.
Genomics and network formation in the pharmaceutical industry.
p.
280.
Argyres, Nicholas S.
and
Liebeskind, Julia Porter
2001.
Governance Inseparability and the Evolution of the U.S. Biotechnology Industry.
SSRN Electronic Journal,
Mowery, David C
Nelson, Richard R
Sampat, Bhaven N
and
Ziedonis, Arvids A
2001.
The growth of patenting and licensing by U.S. universities: an assessment of the effects of the Bayh–Dole act of 1980.
Research Policy,
Vol. 30,
Issue. 1,
p.
99.
Sorenson, Olav
and
Fleming, Lee
2001.
Science and the Diffusion of Knowledge.
SSRN Electronic Journal,
Graff, Gregory D.
Rausser, Gordon C.
and
Small, Arthur A.
2001.
Agricultural Biotechnology's Complementary Intellectual Assets.
SSRN Electronic Journal,
Cook-Deegan, Robert Mullan
and
McCormack, Stephen J.
2001.
Patents, Secrecy, and DNA.
Science,
Vol. 293,
Issue. 5528,
p.
217.
Lacetera, Nicola
2001.
Corporate Governance and the Governance of Innovation: The Case of Pharmaceutical Industry.
Journal of Management and Governance,
Vol. 5,
Issue. 1,
p.
29.
Garen, John E.
and
Chang, Koyin
2001.
Residual Income Claimancy, Monitoring, and the R&D Firm: Theory with Application to Biotechs.
SSRN Electronic Journal ,